| __timestamp | Celldex Therapeutics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 301600000 |
| Thursday, January 1, 2015 | 5480000 | 293461000 |
| Friday, January 1, 2016 | 6786000 | 301853000 |
| Sunday, January 1, 2017 | 12743000 | 331378000 |
| Monday, January 1, 2018 | 9538000 | 343374000 |
| Tuesday, January 1, 2019 | 3573000 | 347337000 |
| Wednesday, January 1, 2020 | 7418000 | 339410000 |
| Friday, January 1, 2021 | 4651000 | 425208000 |
| Saturday, January 1, 2022 | 2357000 | 935061000 |
| Sunday, January 1, 2023 | 6883000 | 1296429000 |
Data in motion
In the dynamic world of biotechnology and pharmaceuticals, revenue trends offer a glimpse into the financial health and market positioning of companies. Over the past decade, Lantheus Holdings, Inc. and Celldex Therapeutics, Inc. have showcased contrasting revenue trajectories.
Lantheus Holdings has demonstrated a robust growth pattern, with revenue surging by over 330% from 2014 to 2023. This impressive growth reflects the company's strategic advancements and market expansion, particularly evident in the significant leap from 2021 to 2023, where revenue nearly tripled.
Conversely, Celldex Therapeutics has experienced a more volatile revenue journey. Despite a peak in 2017, the company faced fluctuations, with a notable dip in 2022. However, a recovery in 2023 suggests potential stabilization and growth opportunities.
These trends underscore the diverse challenges and opportunities within the biotech sector, highlighting the importance of strategic innovation and market adaptation.
Merck & Co., Inc. vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Pfizer Inc. vs Celldex Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Genmab A/S or Lantheus Holdings, Inc.: Who Leads in Yearly Revenue?
Bio-Techne Corporation vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Jazz Pharmaceuticals plc vs Celldex Therapeutics, Inc.
Halozyme Therapeutics, Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. and ImmunityBio, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Lantheus Holdings, Inc. vs Evotec SE
Vericel Corporation or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Ligand Pharmaceuticals Incorporated vs Celldex Therapeutics, Inc.: Annual Revenue Growth Compared
Celldex Therapeutics, Inc. vs Xencor, Inc.: Annual Revenue Growth Compared